Under FDA Clinical Hold, Aardvark Therapeutics Seeks Path Forward for Metabolic Drug

The full FDA clinical hold formally halts all tests of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a rare inherited metabolic disorder that leads to excessive eating. Earlier this year, Aardvark voluntarily paused all tests of its small molecule after a cardiovascular problem emerged in a healthy volunteer. The post Under FDA Clinical Hold, Aardvark Therapeutics…

Read More

Four Reasons ECMO Programs Stall

ECMO is specialized enough that the learning curve carries real clinical and financial consequences, and there is no shortcut to the institutional knowledge that takes years to accumulate. The post Four Reasons ECMO Programs Stall appeared first on MedCity News.

Read More

Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously 

Shyld AI has raised $13.4 million to expand its AI-powered UV disinfection platform, which autonomously sanitizes hospital rooms. The startup’s technology aims to reduce the risk of hospital-acquired infection, as well as lessen hospitals’ reliance on labor-intensive cleaning workflows. The post Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously  appeared first on…

Read More

A Culture of Safety: Patient Transport Success at Novant Health Rowan Medical Center

The Patient Transport team at Novant Health Rowan Medical Center is a strong example of Crothall’s commitment to workplace safety in action.  Crothall Healthcare’s Patient Transport team, located in Salisbury, N.C., makes over 68,000 trips a year and has achieved impressive safety milestones: no major injuries since January 2017 and no ‘Red Rule’ violations for more than eight…

Read More